Brief: Xspray Q2 Adj. EPS at SEK -2.27

Xspray Pharma publ AB

02/08/2023 07:00

Aug 2 (Reuters) - Xspray Q2 adjusted EPS SEK -2.27.
* Q2 adjusted free cash flow SEK -56.503 million
* Q2 pretax profit SEK -51.402 million
* Q2 revenue SEK 0